NM_000218.3:c.1810dupC
Variant summary
Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PVS1_StrongPM2PP5
The NM_000218.3(KCNQ1):c.1810dupC(p.Gln604ProfsTer48) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000218.3 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 7 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Long QT syndrome Pathogenic:1
For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the KCNQ1 protein in which other variant(s) (p.Arg632Glnfs*20) have been determined to be pathogenic (PMID: 16981927, 19825999, 25187895). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. ClinVar contains an entry for this variant (Variation ID: 928774). This variant is also known as 1811insC (D603fs+47X). This premature translational stop signal has been observed in individual(s) with long QT syndrome (PMID: 19716085, 30847666). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Gln604Profs*48) in the KCNQ1 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 73 amino acid(s) of the KCNQ1 protein. -
Cardiac arrhythmia Pathogenic:1
Variant summary: KCNQ1 c.1810dupC (p.Gln604ProfsX48) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant was absent in 185902 control chromosomes (gnomAD). c.1810dupC has been reported in the literature in an individual affected with Arrhythmia (Kapplinger_2009). These data do not allow any conclusion about variant significance. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as likely pathogenic. -
not provided Uncertain:1
Reported in one individual from a cohort of individuals referred for LQTS genetic testing; however, specific clinical details and segregation studies were not reported (Kapplinger et al., 2009); Not observed in large population cohorts (Lek et al., 2016); Frameshift variant predicted to result in protein truncation as the last 73 amino acids are lost and replaced with 47 incorrect amino acids; however, only a few loss-of-function variants have not been reported downstream of this position in the protein (Stenson et al., 2014); This variant is associated with the following publications: (PMID: 19716085, 30847666) -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at